ABOS (ABOS) Stock Price & Analysis
ABOS (ABOS) rose 2.91% to USD 3.18 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
ABOS last closed at USD 3.18; the session ranged USD 3.03–3.23 on volume of 315,433 shares. Market capitalization is —, with a 52-week range of USD 1.21–3.6 (NMS). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 3.18 |
|---|---|
| Change | ▲ 2.91% (up) |
| Previous Close | USD 3.18 |
| Open | USD 3.18 |
| Day Range | USD 3.03 – 3.23 |
| 52-Week Range | USD 1.21 – 3.6 |
| Volume | 315,433 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ABOS)
Nexqual's technical model rates ABOS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 69.05 (neutral) |
| vs SMA50 | Above (USD 2.59) |
| MACD | 0.17 (positive) |
From ABOS's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 3.37% |
| JBIO | Jade Biosciences, Inc. | USD 19.9 | ▼ 7.01% |
| ABVC | ABVC Biopharma, Inc. | USD 0.96 | ▲ 10.98% |
| ACXP | Acurx Pharmaceuticals, Inc. | USD 1.42 | ▼ 0.7% |
| ANNX | Annexon, Inc. | USD 4.87 | ▼ 1.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.